Fixed dose combination formulations containing Lipitor
Ranbaxy Laboratories after finding small glass particles in some lots of Atorvastatin, the generic name for Pfizer's blockbuster drug Lipitor
has called back some packages of its generic version of cholesterol-lowering drug Lipitor
from the US market.
didn't take a passive position when its blockbuster cholesterol-lowering medicine Lipitor
began encountering generic competition last fall.
2 December 2011 - Israeli Teva Pharmaceutical Industries Ltd (TLV:TEVA) said yesterday that it had obtained tentative approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, the generic version of Pfizer's (NYSE:PFE) cholesterol drug Lipitor
Atorvastatin Calcium Tablets are the generic version of Pfizer's Lipitor
The company, the world's biggest drugmaker, is also betting on products brought by buying rival Wyeth for $68 billion in October to help replace sales when generic copies of Lipitor
come onto the market.
Special Considerations: In the Treating to New Targets (TNT) trial, which was the basis of this approval, people on 80 mg of Lipitor
per day had more serious adverse events (2%) and discontinuations because of adverse events (10%) over 5 years, compared with those on the 10-mg dose (1% and 8%, respectively).
won a significant victory on Wednesday when a British judge upheld a key patent covering its blockbuster cholesterol drug Lipitor
in the United Kingdom but the medication still faces a similar, yet more important, case in the United States.
Reader: I have taken Lipitor
for a number of years and just learned that grapefruit juice is contraindicated when taking it.
A study co-written by heart expert Eoin O'Brien found those who took anti-cholesterol tablet Lipitor
, made by Pfizer in Cork, also had fewer strokes.
The industry is bracing itself for the impact of the Lipitor
(atorvastatin, Pfizer) patent cliff which is anticipated to cause large shifts in the antidyslipidemic market.
NEW YORK -- As 2011 was nearing a close, an era was also beginning to end for Lipitor
, once Pfizer Inc.